This is a really interesting study published in PLOS ONE today. Eessentially it's a survey of the attitudes of 2300 participants in TwinsUK (a national biobank) to giving their consent to medical research. The full paper can be found here. The results of the survey would seem to highlight what has been a growing theme in the … Continue reading Consent for medical research comes under scrutiny yet again: time for ethics committees to stop second-guessing the public?
NRES
Who are the good, the bad and the ugly at involving the public in medical research? New comparative figures for Government, charities and industry
What should we make of the latest figures from INVOLVE and the Health Research Authority (HRA) showing which funders are best at public involvement in research? In a re-run of an joint-exercise first done in 2010, INVOLVE and the HRA looked at the public involvement component of over 1100 research applications that went before research ethics … Continue reading Who are the good, the bad and the ugly at involving the public in medical research? New comparative figures for Government, charities and industry
Text of speech to INVOLVE 2012 – Public involvement in research: would you like that shaken or stirred?
Public involvement in research: would you like that shaken or stirred? So, ladies and gentlemen, there I was on Saturday afternoon, at the pictures, watching the new James Bond movie, ‘Skyfall.’ This was background research for today you understand; listening to Adele dolefully sing: ‘This is the end’ which is the opening line of the … Continue reading Text of speech to INVOLVE 2012 – Public involvement in research: would you like that shaken or stirred?
Have charities really put the brakes on public involvement in research?
I was pulled-over by the police on the M25 on Sunday night. Unbeknown to me, my car brake lights had failed so that they were permanently on. Quite apart from blinding any traffic on my tail, an unwitting driver could easily have mis-read my intentions with who knows what consequences. Thankfully that didn't happen. And by … Continue reading Have charities really put the brakes on public involvement in research?
In defence of the clinical trial patient: a health research ombudsman?
Over a half a million members of the British public took part in clinical trials through the NIHR Clinical Trials Research Networks in 2010, a 24% increase on the year before. Those are the Government's figures, not mine. Last week's 'life sciences' announcement included a range of measures to increase patient recruitment to trials. These include … Continue reading In defence of the clinical trial patient: a health research ombudsman?
Health Research Authority (HRA) commits to public involvement from day one
The Health Research Authority (HRA) has published the plan for what it will be up too in the months leading up to March 2012. Really pleased to see a commitment under the Governance section (para 3.3) to develop a comprehensive plan for public and patient involvement. You'll see the statement mentions working with both INVOLVE and AMRC … Continue reading Health Research Authority (HRA) commits to public involvement from day one
Pinch, punch, first day….of the Health Research Authority (HRA)
HRA is established today as a Special Health Authority. I believe further details will be published a bit later and I'll post them here accordingly. But you might want to keep checking the website of the National Research Ethics Service (NRES). 'Anon,' as the bard used to say.
Patients, ethics committees and clinical research – NRES/INVOLVE report highlights ‘public’ challenge for new health research regulator (HRA)
Sometimes you are just defeated by the brilliance of others. So, if you are looking for a wonderful summary of what the autumn statement means for health research, then I can highly recommend Becky's Policy Pages. Clearly, the opening up of health data is the single most important strategic announcement in today's statement - much … Continue reading Patients, ethics committees and clinical research – NRES/INVOLVE report highlights ‘public’ challenge for new health research regulator (HRA)
Simon Denegri's Lay Review 